Yamada A - Search Results

1

Independent Risk Factors and 2-Year Outcomes of Acute Kidney Injury after Surgery for Congenital Heart Disease.

Hirano D, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, Chiba K, Takemasa Y, Tokunaga A, Ida H. Hirano D, et al. Among authors: yamada a. Am J Nephrol. 2017;46(3):204-209. doi: 10.1159/000480358. Epub 2017 Sep 1. Am J Nephrol. 2017. PMID: 28858859

2

Tolvaptan in a pediatric patient with diuretic-resistant heart and kidney failure.

Hirano D, Kakegawa D, Yamada A, Ito A, Miwa S, Ida H. Hirano D, et al. Among authors: yamada a. Pediatr Int. 2015;57(1):183-5. doi: 10.1111/ped.12590. Pediatr Int. 2015. PMID: 25711263

3

Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.

Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T. Fujinaga S, et al. Among authors: yamada a. Clin Exp Nephrol. 2017 Aug;21(4):671-676. doi: 10.1007/s10157-016-1328-y. Epub 2016 Aug 24. Clin Exp Nephrol. 2017. PMID: 27558467

4

Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy.

Yamada A, Fujinaga S, Sakuraya K, Satoshi A, Hirano D. Yamada A, et al. Clin Exp Nephrol. 2018 Oct;22(5):1143-1149. doi: 10.1007/s10157-018-1553-7. Epub 2018 Mar 8. Clin Exp Nephrol. 2018. PMID: 29520517

5

Glyceraldehyde-3-phosphate dehydrogenase of Mycoplasma pneumoniae induces infection-related glomerulonephritis .

Hirano D, Oda T, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, Takemasa Y, Tokunaga A, Wajima T, Nakaminami H, Noguchi N, Ida H. Hirano D, et al. Among authors: yamada a. Clin Nephrol. 2019 Nov;92(5):263-272. doi: 10.5414/CN109786. Clin Nephrol. 2019. PMID: 31496514

6

Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats.

Yamada A, Yokoo T, Yokote S, Yamanaka S, Izuhara L, Katsuoka Y, Shimada Y, Shukuya A, Okano HJ, Ohashi T, Ida H. Yamada A, et al. Hum Cell. 2014 Apr;27(2):59-67. doi: 10.1007/s13577-013-0082-7. Epub 2014 Feb 5. Hum Cell. 2014. PMID: 24496821

7

Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation.

Yamanaka S, Yokote S, Yamada A, Katsuoka Y, Izuhara L, Shimada Y, Omura N, Okano HJ, Ohki T, Yokoo T. Yamanaka S, et al. Among authors: yamada a. PLoS One. 2014 Jul 15;9(7):e102311. doi: 10.1371/journal.pone.0102311. eCollection 2014. PLoS One. 2014. PMID: 25025381 Free PMC article.

8

Effect of adipose-derived mesenchymal stem cell transplantation on vascular calcification in rats with adenine-induced kidney disease.

Yokote S, Katsuoka Y, Yamada A, Ohkido I, Yokoo T. Yokote S, et al. Among authors: yamada a. Sci Rep. 2017 Oct 25;7(1):14036. doi: 10.1038/s41598-017-14492-9. Sci Rep. 2017. PMID: 29070880 Free PMC article.

9

Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.

Fujinaga S, Ozawa K, Sakuraya K, Yamada A, Shimizu T. Fujinaga S, et al. Among authors: yamada a. Clin Nephrol. 2016 Jun;85(6):340-5. doi: 10.5414/CN108835. Clin Nephrol. 2016. PMID: 27125626

10

Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.

Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T. Fujinaga S, et al. Among authors: yamada a. Pediatr Nephrol. 2015 Apr;30(4):687-91. doi: 10.1007/s00467-014-3034-x. Epub 2015 Jan 10. Pediatr Nephrol. 2015. PMID: 25576066 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,234 results

Search Page

Filters